Inflammatory cells in colonic mucosa

Inflammatory cells in colonic mucosa refers to the pathological infiltration of immune cells—such as neutrophils, T-lymphocytes, B-lymphocytes, and macrophages—into the colonic wall. This phenomenon is the hallmark of inflammatory bowel disease (IBD), where a breakdown in immune tolerance leads to chronic, self-sustaining inflammation and mucosal damage (StatPearls, 2023). These cells drive disease progression by secreting pro-inflammatory cytokines and enzymes that degrade the extracellular matrix, leading to symptoms like diarrhea, rectal bleeding, and abdominal pain (NCBI, 2022). While not a single molecular target, this cellular environment is the primary focus of modern gastroenterological pharmacology. Drugs like anti-TNF antibodies and integrin inhibitors work by either neutralizing the products of these cells or preventing their entry into the mucosa to facilitate tissue repair (PubMed, 2021).

Other names

Colonic inflammatory infiltrateMucosal leukocytesIntestinal immune cellsLamina propria mononuclear cells

Therapeutic agents target the activity of these cells by neutralizing pro-inflammatory cytokines (e.g., TNF-alpha, IL-12/23), inhibiting Janus kinase (JAK) signaling, or blocking integrin-mediated adhesion to prevent cell migration into the colonic tissue (StatPearls, 2023; PubMed, 2021).